The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Malcolm J. Moore

Division of Medical Oncology

Princess Margaret Hospital

Toronto

Canada

[email]@uhn.on.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Medical Oncology, Princess Margaret Hospital, Toronto, Canada. 2007
  • Department of Medicine, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Canada. 2002 - 2005

References

  1. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Moore, M.J., Goldstein, D., Hamm, J., Figer, A., Hecht, J.R., Gallinger, S., Au, H.J., Murawa, P., Walde, D., Wolff, R.A., Campos, D., Lim, R., Ding, K., Clark, G., Voskoglou-Nomikos, T., Ptasynski, M., Parulekar, W. J. Clin. Oncol. (2007) [Pubmed]
  2. Brief communication: a new combination in the treatment of advanced pancreatic cancer. Moore, M.J. Semin. Oncol. (2005) [Pubmed]
  3. Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group. Townsley, C.A., Chi, K., Ernst, D.S., Belanger, K., Tannock, I., Bjarnason, G.A., Stewart, D., Goel, R., Ruether, J.D., Siu, L.L., Jolivet, J., McIntosh, L., Seymour, L., Moore, M.J. J. Clin. Oncol. (2003) [Pubmed]
  4. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Moore, M.J., Hamm, J., Dancey, J., Eisenberg, P.D., Dagenais, M., Fields, A., Hagan, K., Greenberg, B., Colwell, B., Zee, B., Tu, D., Ottaway, J., Humphrey, R., Seymour, L. J. Clin. Oncol. (2003) [Pubmed]
  5. Pancreatic cancer: what the oncologist can offer for palliation. Moore, M.J. Can. J. Gastroenterol. (2002) [Pubmed]
 
WikiGenes - Universities